Medrodė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | - | 8,600 | 5,950 | 13,917 | 94,368 |
| Profit before tax | -1,504 | -2,162 | -1,907 | -817 | - | - | - | - |
| Net profit | -1,504 | -2,162 | -1,907 | -817 | 1,524 | -913 | 3,460 | 21,846 |
| Equity | 2,292 | 734 | 989 | 2,079 | 3,603 | 2,690 | 6,150 | 27,996 |
| Liabilities | 16,948 | 17,366 | 16,059 | 15,752 | 15,782 | 18,245 | 17,868 | 32,783 |
| Non-current assets | 19,152 | 18,100 | 17,048 | 15,996 | 16,593 | 15,541 | 14,488 | 13,436 |
| Current assets | 88 | 0 | 0 | 1,835 | 2,792 | 5,394 | 9,530 | 47,270 |
| Total assets | 19,240 | 18,100 | 17,048 | 17,831 | 19,385 | 20,935 | 24,018 | 60,706 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 555 | 610 | 5,806 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | -30.8% | +133.9% | +578.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -7.8% | -11.9% | -11.2% | -4.6% | 7.9% | -4.4% | 14.4% | 36.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -65.6% | -294.6% | -192.8% | -39.3% | 42.3% | -33.9% | 56.3% | 78.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 17.7% | -15.3% | 24.9% | 23.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 7.4 | 23.7 | 16.2 | 7.6 | 4.4 | 6.8 | 2.9 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | 8,600 | 5,950 | 13,917 | 51,474 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medrodė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 707.92 |
| 2026-08-19 | 2026-08-19 | 707.92 |
| 2026-08-16 | 2026-08-17 | 1.91 |
| 2026-07-28 | 2026-08-14 | 1.91 |
| 2026-07-27 | 2026-07-27 | 710.50 |
| 2026-07-26 | 2026-07-26 | 708.59 |
| 2026-07-23 | 2026-07-25 | 710.50 |
| 2026-07-19 | 2026-07-22 | 708.59 |
| 2026-07-16 | 2026-07-17 | 708.59 |
| 2026-06-16 | 2026-06-24 | 236.89 |
| 2026-05-17 | 2026-05-24 | 469.11 |
| 2026-03-27 | 2026-03-27 | 691.25 |
| 2026-03-17 | 2026-03-25 | 691.25 |
| 2026-02-18 | 2026-02-23 | 710.92 |
| 2026-01-21 | 2026-02-17 | 1.59 |
| 2026-01-16 | 2026-01-20 | 696.44 |
| 2025-12-16 | 2025-12-30 | 382.06 |
| 2024-05-16 | 2024-05-22 | 5.69 |
| 2024-04-16 | 2024-04-17 | 5.68 |
| 2024-03-18 | 2024-03-21 | 5.68 |
| 2023-10-27 | 2023-11-09 | 0.60 |
| 2023-10-26 | 2023-10-26 | 0.56 |
| 2023-10-25 | 2023-10-25 | 0.60 |
| 2023-10-17 | 2023-10-24 | 0.56 |
| 2023-09-18 | 2023-10-09 | 0.56 |
| 2023-08-22 | 2023-09-07 | 0.56 |
| 2023-08-17 | 2023-08-21 | 26.05 |
| 2023-07-24 | 2023-08-16 | 0.56 |
| 2023-07-18 | 2023-07-23 | 0.55 |
| 2023-06-16 | 2023-07-04 | 0.55 |
| 2023-05-22 | 2023-06-13 | 0.55 |
| 2023-03-16 | 2023-04-10 | 0.49 |
| 2023-02-28 | 2023-03-06 | 0.49 |
| 2023-02-17 | 2023-02-27 | 25.49 |
| 2022-12-16 | 2022-12-18 | 23.97 |
| 2022-11-17 | 2022-11-18 | 23.97 |
| 2022-08-23 | 2022-08-25 | 23.97 |
| 2022-07-18 | 2022-08-10 | 23.97 |
| 2022-06-16 | 2022-07-04 | 23.97 |
| 2022-01-03 | 2022-01-31 | 0.18 |
| 2021-11-03 | 2021-12-31 | 0.18 |
| 2021-08-01 | 2021-10-31 | 0.18 |
Medrodė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-03 | 2026-07-07 | 600.96 |
| 2026-06-30 | 2026-07-02 | 3842.92 |
| 2026-06-19 | 2026-06-29 | 3843.02 |
| 2025-09-30 | 2025-10-09 | 0.12 |
| 2025-09-28 | 2025-09-29 | 116.01 |
| 2025-04-04 | 2025-04-08 | 0.35 |
| 2025-04-02 | 2025-04-03 | 0.3 |
| 2025-03-30 | 2025-04-01 | 180.03 |
| 2025-03-09 | 2025-03-29 | 0.21 |
| 2025-03-05 | 2025-03-08 | 0.09 |
| 2025-03-02 | 2025-03-04 | 107.33 |
| 2025-02-28 | 2025-03-01 | 107.27 |
| 2025-02-20 | 2025-02-27 | 0.24 |
| 2025-02-06 | 2025-02-10 | 0.24 |
| 2025-02-03 | 2025-02-05 | 0.16 |
| 2025-02-02 | 2025-02-02 | 141.52 |
| 2025-01-30 | 2025-02-01 | 141.4 |
| 2024-02-18 | 2024-10-16 | 0.36 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medrode, UAB (code 135657366) is a Private Limited Liability Company engaged in materials recovery. In the latest financial year, 2025, the company generated revenue of €94.4K and net profit of €21.8K, resulting in a profit margin of 23.1%. Revenue expanded sharply from €13.9K in 2024 and €6.0K in 2023, while net profit improved from a loss of €913 in 2023 to a profit of €3.5K in 2024 and €21.8K in 2025. Over the same period, total assets increased to €60.7K from €24.0K a year earlier, supported by equity of €28.0K and liabilities of €32.8K. Long-term assets stood at €13.4K and short-term assets at €47.3K at the end of 2025, indicating a stronger current asset base. Key ratios point to solid operating efficiency, with ROE at 78.0%, ROA at 36.0%, debt-to-equity at 1.17, and asset turnover at 1.55x. Revenue per employee was €94.4K, and profit per employee was €21.8K.